ETODOLAC - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for etodolac and what is the scope of patent protection?

Etodolac is the generic ingredient in three branded drugs marketed by Ani Pharms, Apotex, Biopharm, Chartwell Molecules, Ipca Labs Ltd, Mylan, Natco Pharma, Sandoz, Taro, Wyeth Pharms Inc, Actavis Elizabeth, Bayshore Pharms Llc, Teva, Watson Labs Florida, Zydus Pharms, Amneal Pharms Co, Apotex Inc, Edenbridge Pharms, Ivax Sub Teva Pharms, Oxford Pharms, Pangea, Ranbaxy Labs Ltd, Shree Hari Intl, Taro Pharm Inds, and Watson Labs, and is included in forty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-three drug master file entries for etodolac. Thirty-one suppliers are listed for this compound.

Summary for ETODOLAC

US Patents:	0
Tradenames:	3
Applicants:	25
NDAs:	41
Drug Master File Entries:	23
Finished Product Suppliers / Packagers:	31
Raw Ingredient (Bulk) Api Vendors:	118
Clinical Trials:	29
Patent Applications:	6,966
Drug Prices:	Drug price trends for ETODOLAC
Drug Sales Revenues:	Drug sales revenues for ETODOLAC
What excipients (inactive ingredients) are in ETODOLAC?	ETODOLAC excipients list
DailyMed Link:	ETODOLAC at DailyMed

See drug prices for ETODOLAC

See drug sales revenues for ETODOLAC

Recent Clinical Trials for ETODOLAC

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Kutahya Health Sciences University	Phase 4
Memorial Sloan Kettering Cancer Center	N/A
Apsen Farmaceutica S.A.	Phase 3

See all ETODOLAC clinical trials

Pharmacology for ETODOLAC

Drug Class	Nonsteroidal Anti-inflammatory Drug
Mechanism of Action	Cyclooxygenase Inhibitors

Medical Subject Heading (MeSH) Categories for ETODOLAC

Cyclooxygenase 2 Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for ETODOLAC

M01AB	Acetic acid derivatives and related substances
M01A	ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
M01	ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
M	Musculo-skeletal system

US Patents and Regulatory Information for ETODOLAC

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva	ETODOLAC	etodolac	TABLET;ORAL	075009-002	Dec 28, 1999		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ipca Labs Ltd	ETODOLAC	etodolac	CAPSULE;ORAL	205448-001	Aug 1, 2024	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Mylan	ETODOLAC	etodolac	CAPSULE;ORAL	075071-001	Sep 30, 1998		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Taro	ETODOLAC	etodolac	TABLET, EXTENDED RELEASE;ORAL	076174-001	Mar 13, 2003	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Teva	ETODOLAC	etodolac	TABLET, EXTENDED RELEASE;ORAL	075665-002	Jul 31, 2000	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for ETODOLAC

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Wyeth Pharms Inc	LODINE	etodolac	CAPSULE;ORAL	018922-003	Jan 31, 1991	⤷ Sign Up	⤷ Sign Up
Wyeth Pharms Inc	LODINE	etodolac	CAPSULE;ORAL	018922-002	Jan 31, 1991	⤷ Sign Up	⤷ Sign Up
Wyeth Pharms Inc	LODINE	etodolac	TABLET;ORAL	018922-004	Jul 29, 1993	⤷ Sign Up	⤷ Sign Up
Wyeth Pharms Inc	LODINE	etodolac	CAPSULE;ORAL	018922-003	Jan 31, 1991	⤷ Sign Up	⤷ Sign Up
Wyeth Pharms Inc	LODINE XL	etodolac	TABLET, EXTENDED RELEASE;ORAL	020584-003	Jan 20, 1998	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.